Two Blokes

Barclays: The pharma sector is very out of favor for tariffs

  • click to rate
    Posted by Two Blokes Jul 14 - Filed in Stock - 1 view
    Emily Field, head of European pharma research at Barclays, discusses which drug makers would be most impacted by 30% U.S. tariffs on EU imports, and the likelihood President Trump moves ahead with up to 200% tariffs on foreign pharma products.